Brief: Biovica International: Divitumtka Results From Bioitalee Study Presented At Esmo

Biovica International AB

14/09/2021 07:12

Sept 14 (Reuters) - Biovica International AB  BIOVICb.ST :
    * PROMISING DIVITUMTKA RESULTS FROM BIOITALEE STUDY
PRESENTED AT
ESMO
    * STUDY CONCLUDES THAT TKA APPEARS TO BE A NEW PROMISING
PROGNOSTIC, PREDICTIVE AND MONITORING BIOMARKER IN PATIENTS
    * BASELINE AND DYNAMIC TKA CHANGES PROVIDED INDEPENDENT
VALUABLE
INFORMATION
    * LACK OF TKA SUPPRESSION AT DAY 15 INDICATES ENRICHMENT FOR
PRIMARY RESISTANCE AND POOR PROGNOSIS

Source text for Eikon:  ID:nMFNpcVWg 
Further company coverage:  BIOVICb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))